Meta-analysis of 9 studies of PENTO or PENTOCLO for osteoradionecrosis: pooled adverse effect proportion was 15%, mostly gastrointestinal; adverse effects were more frequent in treatment settings and with PENTOCLO (28%). No MRONJ data.
Meta-analysisn = 9 studies
Ribeiro et al. Adverse effects of the PENTO(CLO) protocol in the prevention and management of iatrogenic head and neck bone necrosis in cancer patients: A systematic review and meta-analysis